InvestorsHub Logo
Followers 72
Posts 6896
Boards Moderated 0
Alias Born 12/07/2011

Re: scottsmith post# 200380

Tuesday, 10/17/2017 2:55:05 PM

Tuesday, October 17, 2017 2:55:05 PM

Post# of 403095
As they publicly stated. P results for phase 2a are comparable to Otezla at the same phase. Now we optimized dosing. We should crush it imo. And preclinical psoriasis is much more straight forward and predictable per the community. I think P is a shoe in to match Otezla.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News